Access provided by Autonomous University of Puebla. Download chapter PDF
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Scientific Name
Chrysanthemum indicum L.
Synonyms
Achillea bandana Buch.-Ham., Achillea berdana Buch.-Ham. ex DC., Arctotis elegans Thunb., Bidens bardanna Wall., Bidens marginata DC., Chrysanthemum indicum var. albescens Makino, Chrysanthemum indicum var. hiberinumj Makino, Chrysanthemum indicum var. indicum, Chrysanthemum japonicum Thunb., Chrysanthemum japonicum var. japonicum, Chrysanthemum koraiense Nakai, Chrysanthemum procumbens Lour., Chrysanthemum purpureum Pers., Chrysanthemum tripartitum Sweet, Dendranthema indicum (L.) Des Moulin, Matricaria indica (L.) Ramat., Pyrethrum indicum (L.) Cass., Tanacetum indicum (L.) Schultz-Bip.
Family
Asteraceae
Common/English Names
Chinese Chrysanthemum, Indian Chrysanthemum, False Camomile, Garden Camomile, Ground Apple, Indian Chrysanthemum, Mother’s Daisy, Roman Camomile, Whig Plant, Winter Aster
Vernacular Names
-
Catalan: Crisantem De L’Índia, Malabars
-
Chinese: Ye Ju, Ye Ju Hua, You Je
-
Czech: Listopadka Indická
-
Danish: Krysantemum
-
French: Chrysanthème Des Indes, Chrysantheme D’automne
-
Galician: Crisantemo
-
German: Winteraster
-
India: Chandramallika (Hindi), Sevanti (Sanskrit)
-
Japanese: Abura-Giku,Hama-Kangiku, Shima-Kangiku, Yagikka
-
Korean: Gamguk
-
Malaysia: Kekwa
-
Philippines: Mansanilya-A-Babasit (Iloko), Manzanilla (Spanish), Dolontas, Mansanilya (Tagalog)
-
Romanian: Floare De Toamnă, Tufănică
-
Spanish: Crisantelo, Crisantelmo, Crisantemo, Crisantemos, Margarita, Margaritas
-
Thai: Khek-Huay
-
Vietnam: Cúc Hoa, Cúc Hoa Vang, Kim Cúc, Hoàng Cúc, Dã Cúc, Cam Cúc, Kh ỏ Ý, Biooc Kim
Origin/Distribution
The plant is indigenous to East Asia—Eastern China and central and southern Japan. It is cultivated as a medicinal plant in India, Vietnam, China and Japan and introduced into many countries as a garden ornamental. In the Philippines, it is cultivated at 1,800 m altitude in Benguet sub-province.
Agroecology
In its native range, it occurs in grasslands on mountain slopes, thickets, wet places by rivers, fields, roadsides, saline places by seashores and under shrubs from elevation of 100–2,900 m. The plant is hygrophilous and slightly shade tolerant. The plant thrives on fertile alluvial or sandy-loam soil that is well drained but sufficiently moist. It grows well in areas with temperatures of 15–30 °C and with mean annual rainfall between 1,000 and 2,000 mm.
Edible Plant Parts and Uses
In Japan, the flower heads are eaten (marinated in vinegar) (Uphof 1968; Usher 1974; Facciola 1990); in China, they are also used as a vegetable and as an aromatic plant. Dried flowers are used in mixed spices and as food additives for masking flavors, used in making an aromatic herbal tea, and used in beverages after sweetening with sugar or honey and alcoholic beverages in Korea since ancient times (Chang and Kim 2008; Chun et al. 2008). The young leaves are seasoned in combination with Acorus gramineus, aff. Angelica, Eupatorium lindleyana, Sedum aff. sarmentosum, and Sedum aff. spectabile and eaten cooked with chicken by the Hmong ethnic group of Vietnam (Corlett et al. 2002).
Botany
Annual or perennial herb, 25–100 cm tall with an erect, sulcate, glabrous, sparingly branched, green stem and short procumbent rhizomes. Leaves alternate, dark green above and pale green below, ovate to elliptic ovate, deeply lobed and irregularly toothed, base cuneate to truncate, apex acute, sparsely hairy to subglabrous on both sides, and on 1–2 cm long petioles (Plate 1 and 2). Inflorescence in axillary or terminal corymb of many small heads, long peduncled, 1–1.5 cm in diameter (Plates 1, 2 and 3). Involucre of many elliptical bracts in 5 rows, flowers yellow, outer ray florets ligulate with 5 mm long, central disc florets tubular; corolla 2.5 mm long, obovoid and glabrous. The achenes are very small, cuneate-oblong, somewhat compressed and grooved.
Nutritive/Medicinal Properties
Flower Nutrients/Phytochemicals
Mineral elements found in the flowers were K 37.55 mg/g, P 4.8 mg/g, Ca 9.73 mg/g, Mg 3.01 mg/g, Na 0.77 mg/g, Fe 1426.63 μg/g, Mn 109.22 μg/g, Zn 58.2 μg/g, Cu 19.95 μg/g, and Mo 0.37 μg/g (Cui and Guo 2012).
Chrysanthemum indicum flowers were found to contain a sesquiterpene lactone, arteglasin-A (Hausen et al. 1975; Hausen and Schulz 1976). A sesquiterpene lactone of guaianolide-type, yejuhua lactone, was isolated from the flowers and later confirmed to be handelin (Chen and Xu 1987). The flowers contained chrysanthemaxanthine, chrysanthemin (asterin, kuromamin) luteolin glucoside, n-hexacosane, n-tetracosane, stachydrine, adenine and vitamin A (Le and Nguyen 1999). Three new eudesmane-type sesquiterpenes called kikkanols A, B, and C; flavones, luteolin and eupatilin; three flavone glycosides luteolin 7-O-β-d-glucopyranoside, luteolin 7-O-β-d-glucopyranosiduronic acid, and acacetin 7-O-(60-α-l-rhamnopyranosyl)-β-d-glucopyranoside; two polyacetylenes cis-spiroketalnenolether polyyne and trans-spiroketalenolether polyyne; three sesquiterpenes clovanediol, caryolane 1,9β-diol, and oplopanone; and chlorogenic acid were isolated from the flowers (Yoshikawa et al. 1999). Five germacrane-type sesquiterpenes kikkanols D, D monoacetate, E, F, and F monoacetate and chrysanthemol (trans-eudesmane type sesquiterpene) were isolated from the flowers (Yoshikawa et al. 2000). Two flavanone glycosides, (2S)-eriodictyol 7-O-β-d-glucopyranosiduronic acid and (2R)-eriodictyol 7-O-β-d-glucopyranosiduronic acid, and a phenylbutanoid glycoside, (2S, 3S)-1-phenyl-2,3-butanediol 3-O-β-d-glucopyranoside and flavonoids: apigenin 7-O-β-d-glucopyranoside (apigetrin); diosmetin 7-O-β-d-glucopyranoside; quercetin 3,7-di-O-β-d-glucopyranoside; eriodictyol; (2S, 3S)-1-phenyl-2,3-butanediol, luteolin, luteolin 7-O-β-d-glucopyranoside; luteolin 7-O-β-d-glucopyranosiduronic acid; acacetin 7-O-(60-α-l-rhamnopyranosyl)-β-d-glucopyranoside; and eupatilin were isolated from the flowers (Matsuda et al. 2002). From the methanol flower extract were isolated: two polyacetylenes (cis-spiroketalenolether polyyne and trans-spiroketalenolether polyyne), eleven sesquiterpenes (kikkanol A, kikkanol B, kikkanol C, kikkanol D, kikkanol D monoacetate, kikkanol E, kikkanol F, kikkanol F monoacetate, clovanediol, caryolane 1,9β-diol, oplopanone), ten aromatic flavonoids ((2S)-eriodictyol 7-O-β-d-glucopyranosiduronic acid, (2R)-eriodictyol 7-O-β-d-glucopyranosiduronic acid, eupatilin, luteolin, luteolin 7-O-β-d-glucopyranosid, luteolin 7-O-β-d-glucopyranosiduronic acid, apigenin 7-O-β-d-glucopyranoside, diosmetin 7-O-β-d-glucopyranoside, acatin-7-O-(6″-α-l-rhamnopyranosyl)-β-d-glucopyranoside, quercetin 3,7-di-O-β-d-glucopyranoside), and two other aromatics (a phenylbutanoid glycoside (2S,3S)-1-phenyl-2,3-butanediol 3-O-β-d-glucopyranoside and chlorogenic acid) (Morikawa 2007).
Seven compounds were isolated 80 % ethanol flower extract: acacetin, acacetin-7-O-(6″-O-acetyl) β-d-glucopyranoside, linarin, apigenin-7-O-β-d-glucopyranoside, chlorogenic acid, vanillic acid and sucrose (Gao et al. 2008). Tang et al. (2009) isolated seven compounds from the 80 % ethanol flower extract luteolin, luteolin-7-O-β-d-glucopyranoside, luteolin-7-O-(6″-O-acetyl)-β-d-glucopyranoside, diosmetin, diosmetin-7-O-β-d-glucopyranoside, eupatilin and apigenin. Lu et al. (2009) isolated seven compounds from the flowers: acacetin, apigenin, acacetin-7-O-β-d-glucopyranoside, apigenin-7-O-β-d-glucopyranoside, luteolin, β-sitosterol and daucosterol. Thirteen compounds were isolated from the flowers, and identified as acacetin-7-O-β-d-glucopyranoside (1), luteolin (2), luteolin-7-O-β-d-glucopyranoside (3), acaciin (4), acacetin 7-O-(6″-O-α-l-rhamnopyranosyl)-β-sophoroside (5), 3-O-caffeoylquinic acid (6), syringaresinol O-β-d-glucopyranoside (7), 5,7-dihydroxychromone (8), uracil (9), p-hydroxybenzoic acid (10), 4-O-β-d-glucopyranosyloxybenzoic acid (11), boscialin (12) and blumenol A (13) (Feng et al. 2010). Four new polyacetylenes, namely, chrysindins A–D, together with 6 known polyacetylenes, were isolated from the flowers (Liu et al. 2011).
Twelve compounds were isolated and identified as acacetin; tricin; 2′,4′-dihydroxychalcone; 5-hydroxy-4′,7-dimethoxyflavon; 7-hydroxyflavonone; isorhamnetin (6),5,6,7-trihydroxy- 3′,4′, 5′-trimethoxyflanon; quercetin; (3β, 5α, 6β, 7β, 14β)-eudesmen-3,5,6,11-tetrol; syringaresinol; liriodendrin and genkwanin from the flowers (Wang et al. 2010a). Three germacrane-type sesquiterpene stereoisomers 1β,3α,5β-trihydroxyl-7-isopropenyl-germacren-4(15),10(14)-diene; 1β,3β,5α-trihydroxyl-7-isopropenyl-germacren-4(15),10(14)-diene; 1β,3β,5β-trihydroxyl-7-isopropenyl-germacren-4(15),10(14)-diene were isolated from the flowers (Wang et al. 2012). One new disesquiterpenoid and two new sesquiterpenoids were isolated from the dried flowers (Zhou et al. 2012).
The yield of C. indicum flower oil was 2.0 % (w/w), and 63 volatile flavour components comprising 89.28 % of the total aroma composition were characterized (Chang and Kim 2008). The essential oil contained 35 hydrocarbons (48.75 %), 12 alcohols (19.92 %), 6 ketones (15.31 %), 3 esters (4.61 %), 5 aldehydes (0.43 %), 1 oxide (0.22 %) and 1 miscellaneous component (0.04 %). α-Pinene (14.63 %), 1,8-cineol (10.71 %) and chrysanthenone (10.01 %) were the predominant volatile components. Chang and Kim (2009) reported the yield of flower oils from Korean and Chinese gamguk were 2.0 and 0.5 % (v/w), respectively. Sixty-three volatile compounds of Korean gamguk representing 89.28 % of the total peak area were tentatively identified, including 35 hydrocarbons, 12 alcohols, 6 ketones, 3 esters, 5 aldehydes, 1 oxide, and 1 miscellaneous component. Thirty-six volatile components of Chinese gamguk constituted 58.15 % of the total volatile composition, consisting of 19 hydrocarbons, 7 alcohols, 2 ketones, 2 esters, 4 aldehydes, 1 oxide, and 1 miscellaneous component. The predominant components of Korean oil were α-pinene, 1,8-cineol, and chrysanthenone. Whereas camphor, α-curcumene, and β-sesquiphellandrene were the main aroma compounds of Chinese gamguk. Thirty-six, 63, and 55 volatiles constituents were detected in the essential oil from fresh and shade-dried and freeze-dried flowers (Choi and Kim 2011). Ketones were predominant in the volatiles of gamguk flowers: fresh, 43.8 %; shade dried, 30.3 %; and freeze dried, 36.1 %. Camphor was the most abundant volatile component; borneol was also significant. The content of camphor was higher in fresh sample than those of dried samples, while borneol concentration was significantly increased in the dried samples. Five major components of the flower essential oil are α-pinene, 1,8-cineol, chrysanthenone, germacrene-D, and α-curcumene (Kim and Lee 2009). Germacrene-D decreased by the increase of nitrogen application. However, cumambrin A contents in the flower parts were affected negatively by the increase of nitrogen application, but total yields of cumambrin A in flower parts significantly increased.
Chang et al. (2010) found 63 volatile flavour components which comprised 89.28 % of the total aroma composition of the flower oil. The predominantly abundant volatile chemical components were α-pinene (14.63 %), 1,8-cineol (10.71 %), and chrysanthenone (10.01 %). The other components included germacrene D (5.25 %), β-bisabolene (3.95 %), (−)-sinularene (3.95 %), bornyl acetate (3.64 %), β-elemene (3.18 %), borneol (3.02 %), zingiberene (2.70 %), camphor (2.64 %), terpinene-4-ol (2.41 %), filifolone (2.24 %), γ-terpinolene (2.04 %), (E)-β-farnesene (1.87 %), α-curcumene (1.80 %), isopinocarveol (1.55 %), sabinene (1.24 %), β-sesquiphellandrene (1.19 %), pinocarvone (1.19 %), myrcene (1.17 %) and (E)-chrysanthenol (1.17 %).
Wu et al. (2010a) detected 63 volatiles in the flower essential oil, and the major volatiles included 2,6,6-trimethyl-bicyclo[3.1.1]hept-2-en-4-ol (21.67 %); 2-(2,4-hexadiynylidene)-1,6-dioxaspiro[4.4]non-3-ene (21.41 %); germacrene D (6.15 %); α-neoclovene (5.10 %); eucalyptol (4.94 %); α-pinene (3.64 %); and 1,4-bis(1-methylethyl)-benzene (3.03 %). Other minor constituents included β-sesquiphellandrene (2.90 %), longipinane (2.89 %), 7, 11-dimethyl-3-methylene-1,6,10-dodecatriene (2.17 %), β-myrcene (1.78 %), caryophyllene (1.77 %), 2,6-dimethyl-6-(4-methyl-3-pentenyl)-bicyclo[3.1.1]hept-2-ene (1.71 %), 1,2,3,6-tetramethyl-bicyclo[2.2.2]octa-2,5-diene (1.64 %), 4-(1,5-dimethylhex-4-enyl)cyclohex-2-enone (1.56 %), caryophyllene oxide (1.25 %), isocyclocitral (1.23 %), cadina-1,6,8-triene (0.99 %), α,α-4-trimethyl-3-cyclohexene-1-methanol (0.84 %), 4-methylene-1-(1-methylethyl)-icyclo[3.1.0]hexane (0.74 %), 3,4-dihydro-1-naphthaleneboronic acid diethyl ester (0.71 %), borneol (0.70 %), (Z)-3,7-dimethyl-2,6-octadien-1-ol acetate (0.66 %), trans-3-methyl-6-(1-methylethyl)-2-cyclohexen-1-ol (0.64 %), isobornyl acetate (0.63 %), 1,3,3-trimethylcyclohex-1-ene-4-carboxaldehyde (0.60 %), butylated hydroxytoluene (0.59 %), 4-methyl-1-(1-methylethyl)- 3-cyclohexen-1-ol (0.57 %), (E)-3(10)-caren-2-ol (0.57 %), 2-isopropyl-5-methyl-9-methylene-bicyclo[4.4.0]dec-1-ene (0.53 %), cis-1-methyl-4-(1-methylethyl)-2-cyclohexen-1-ol (0.48 %), iridomyrmecin (0.37 %), benzoic acid, 2-(dimethylamino)-methyl ester (0.37 %), 6,6-dimethyl-2-methylene-icyclo[2.2.1]heptan-3-one (0.35 %), 2-methyl butanoic acid phenylmethyl ester (0.34 %), α-caryophyllene (0.31 %), 5-ethylcyclopent-1-enecarboxaldehyde (0.31 %), camphene (0.30 %), 1,2,5,5-tetramethyl-1,3-cyclopentadiene (0.29 %), 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol (0.29 %), benzyl acetoacetate (0.28 %), 3,7,11-trimethyl-1,3,6,10-dodecatetraene (0.21 %), 6,6-dimethyl-bicyclo[3.1.1]hept-2-ene-2-methanol (0.21 %), 4-dcetyl-3-carene (0.21 %), β-phellandrene (0.19 %), 1-methyl-8-(1-methylethyl)- tricyclo[4.4.0.02,7]dec-3-ene-3-methanol (0.18 %), copaene (0.17 %), 1,5,5-trimethyl-6-methylene-cyclohexene (0.16 %), 3,4-dihydro-2,2-dimethyl-2H-1-benzopyran (0.15 %), (S)-2-methyl-5-(1-methylethenyl)-2-cyclohexen-1-one (0.14 %), 4-methylene-2,8,8-trimethyl-2-vinyl-bicyclo[5.2.0]nonane (0.12 %), 2-n-butyl furan (0.10 %), phytol (0.10 %), 4,6,6-trimethyl- bicyclo[3.1.1]hept-3-en-2-ol (0.09 %), 1,2-diethyl-3,4-dimethyl-benzene (0.09 %), isoaromadendrene epoxide (0.08 %), 2,3-dihydro-2,2,4,6-tetramethyl-benzofuran (0.08 %), alloaromadendrene oxide-(I) (0.08 %), 4,6-dimethyl-2-pyrimidone (0.08 %), 2-methoxy-4-methyl-4-phenyl-2,5-cyclohexadien-1-one (0.07 %), tetracosane (0.07 %), hexatriacontane (0.06 %), and 3,7-dimethyl-1,3,6-octatriene (0.06 %). Further, ten flavonoids (mg/g) were identified, namely, quercitrin 51.88 mg, myricetin 37.81 mg, luteolin-7-glucoside 17.24 mg, quercetin-3-galactoside 12.55 mg, quercetin-3-glucoside 9.88 mg, luteolin 7.29 mg, kaempferol 0.22 mg, vitexin 0.17 mg, rutin 0.16 mg, apigenin 0.09 mg and total flavonoids 137.29 mg (Wu et al. 2010a).
The major constituents of the essential oils from three samples fresh, air-dried and processed flowers of Chrysanthemum indicum were 1,8-cineole, camphor, borneol and bornyl acetate (Zhu et al. 2005). The oils also contained α-terpineol, cis-sabinol, thujone, terpinen-4-ol, ρ-cymene and linalool. Fresh, air-dried and processed flowers of Chrysanthemum indicum shared similar qualitative composition of essential oils; the difference was quantitative. The fresh flower oil had a high percentage of 1.8-cineole (30.41 %) and camphor (23.52 %), although air-dried flower oil had a high content of camphor. Chrysanthemum indicum essential oil also had chrysanthenone, limonene, β-caryophyllene oxide and α-pinene and β-pinene. The essential oils of dried gamguk flowers were composed of hydrocarbons (shade dried (SD) 20.1, freeze dried (FD) 21.9 %), alcohols (SD 39.7, FD 33.9 %), esters (SD 7.7, FD 7.1 %), ketones (SD 30.3, FD 36.1 %), aldehydes (SD 0.1, FD 0.4 %), oxides (SD 0.7, FD 0.1 %), acids (SD 1, FD 0.4 %), and miscellaneous ones (SD 0.4, FD 0.1 %) (Choi and Kim 2011). The oxygenated compounds were important contributors to aromatic flower flavour. Camphor (SD 28.8, FD 35.2 %) and borneol (SD 28.3, FD 24.3 %) were the most abundant volatile component of shade- and freeze-dried samples, respectively. The newly identified compounds in shade-dried sample in comparison with a fresh sample were (3E)-2,5,5-trimethylhepta-1,3,6-triene, isogeraniol, p-cymen-8-ol, myrtenol, cis-piperitol, trans-3(10)-caren-2-ol, 1-methyl-4-(1-methylethyl)-benzene, trans-piperitol, verbenene, 4-ethenyl-1,2-dimethyl-benzene, bicyclogermacrene, α-farnesene, α-muurolene, dicyclohexyl-propanedinitrile, 2,3,6-trimethyl-1,4,6-heptatriene, nerolidol, spathulenol, caryophyllene oxide, 5-ethenyl-2-methyl-pyridine, citral, β-bisabolene, trans-α-bisabolene, α-gurjunene, β-eudesmol, E-3-phenyl-2-propenyl 3-methylbutanoate, valerenic acid, vulgarone B, aromadendrene epoxide, hexadecanoic acid, p-mentha-1(7)2-dien-8-ol, (Z,Z)-9,12-octadecadienoic acid, tricosane and pentacosane. Shade-dried gamguk flower had the greatest total number of volatile flavour compounds. α-Copaene, isobornyl-3-methylbutanoate and heptacosane were the compounds identified in only the freeze-dried sample.
Sixty-three volatile compounds of Korean gamguk representing 89.28 % of the total composition were identified, including 35 hydrocarbons, 12 alcohols, 6 ketones, 3 esters, 5 aldehydes, 1 oxide and 1 miscellaneous component (Chang and Kim 2009). Thirty-six volatile components of Chinese gamguk that constituted 58.15 % of the total volatile composition were characterized, consisting of 19 hydrocarbons, 7 alcohols, 2 ketones, 2 esters, 4 aldehydes, 1 oxide and 1 miscellaneous component. The predominant components of Korean oil were α-pinene, 1,8-cineol and chrysanthenone, whereas camphor, α-curcumene and β-sesquiphellandrene were the main aroma compounds of Chinese gamguk.
A total of 169 compounds representing 88.79–99.53 % of the oils were identified in the flower-head essential oil of 8 Chinese C. indicum populations (Zhang et al. 2010a). The predominant components were 1,8-cineole (0.62–7.34 %), (+)-(1R,4R)-camphor (0.17–27.56 %), caryophyllene oxide (0.54–5.8 %), β-phellandrene (0.72–1.87 %), (−)-(1S,2R,4S)-borneol acetate (0.33–8.46 %), 2-methyl-6-(p-tolyl)hept-2-ene (0.3–8.6 %), 4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-yl acetate (0.17–26.48 %), and hexadecanoic acid (0.72–15.97 %).
Leaf/Aerial Parts Phytochemicals
Mineral elements found in the leaves were K 31.52 mg/g, P 4.28 mg/g, Ca 14.14 mg/g, Mg 2.70 mg/g, Na 0.82 mg/g, Fe 1519.46 μg/g, Mn 186.7 μg/g, Zn 78.04 μg/g, Cu 30.26 μg/g and Mo 0.56 μg/g (Cui and Guo 2012).
Mineral elements found in the stems were K 17.74 mg/g, P 1.45 mg/g, Ca 5.52 mg/g, Mg 1.35 mg/g, Na 0.75 mg/g, Fe 433.36 μg/g, Mn 65.84 μg/g, Zn 76.6 μg/g, Cu 16.34 μg/g and Mo 0.21 μg/g (Cui and Guo 2012).
A flavones glucoside, isolated from C. indicum, identified as acacetin-7-rhamnosidoglucoside was found to be identical with buddleoglucoside (Cheng et al. 1962). The sesquiterpenoid valerone was found in C. indicum (Uchio et al. 1981). Indicumenone, a bisabolane ketodiol, was isolated from C. indicum (Mladenova et al. 1987). Sesquiterpenoids, chrysetunone, chrysetunone monacetate and tunefulin were isolated from aerial parts of C. indicum var. tuneful (Mladenova et al. 1988). A sesquiterpene compound, named chrysanthetriol, was isolated from the more polar fraction of the plant (Yu et al. 1992). (3β, 5α, 6β, 7β, 14β)-Eudesmen-3, 5, 6, 11-tetrol methanol solvate, systematic name: (3S,5S,6R,7R,10S)-7-(2-hydroxy-2-propyl)-10-methyl-4-methyleneperhydronaphthalene-3,5,6-triol methanol solvate, C15H26O4 · CH4O, a new sesquiterpenoid was isolated from C. indicum (Wang et al. 2006). Twelve compounds were obtained from C. indicum fraction with cardiovascular activity and identified as (2S)-eriodictyol-7-O-β-d-glucuronide (1), (2S)-eriodictyol-7-O-β-d-glucoside (2), (2S)-esperetin-7-O-β-d-glucuronide (3), luteolin-7-O-β-d-glucoside (4), luteolin-7-O-β-d-glucuronide (5), diosmetin-7-O-β-d-glucuronide (6), quercetin-7-O-β-d-glucoside (7), (2S)-eriodict-dicaffeoylquinate (8), 3,5-dicaffeoylquinic acid(9), 3,5-cis-dicaffeoylquinic acid (10), 1,5-dicaffeoylquinic acid (11) and 1,3-dicaffeoylquinic acid (12) (Sun et al. 2012). The following compounds were isolated from the methylene chloride fraction of C. indicum crude ethanol extract: sudachitin, hesperetin, chrysoeriol and acacetin (Kim et al. 2013).
Seventy-three compounds accounting for 96.65 % of the extracted essential oil of the aerial parts were identified (Jung 2009). The oil comprised 14.88 % monoterpene hydrocarbons (MH), 52.14 % oxygenated monoterpenes (OM), 22.9 % sesquiterpene hydrocarbons (SH), 5.97 % oxygenated sesquiterpenes (OS) and 0.75 % others (O). The main compounds in the oil were α-pinene (4.4 %, MH), 1,8-cineole (10.4 %, OM), α-thujone (6.05 % OM), camphor (10.12 %, OM), bornyl acetate (6.1 % OM), borneol (3.6 % OM), terpinen-4-ol (3.4 % OM), cis-chrysanthenol (3.4 % OM), β-caryophyllene (5.1 %,SH), germacrene D (10.6 %, SH) and α-cadinol (3.0 %, OS). The minor components included monoterpene hydrocarbons (tricyclene, α-thujene, camphene, β-pinene, sabinene, myrcene, α-terpinene, limonene, α-phellandrene, cis-β-ocimene, γ-terpinene, trans-β-ocimene, p-cymene, terpinolene), oxygenated monoterpenes (α-terpinolene, cis-3-hexen-1-ol, β-thujone, trans-sabinene hydrate, chrysanthenone, linalool, pinocarvone, cis-chrysanthenyl acetate, umbellulone, trans-chrysanthenyl acetate, trans-piperitol, α-terpineol, piperitone, carvone, myrtenol, trans-carveol, p-cymen-8-ol, cis-carveol), sesquiterpene hydrocarbons (α-copaene, α-gurjunene, berkheyaradulen, β-elemene, α-humulene, trans-β-farnesene, α-muurolene, γ-cadinene, α-zingiberene, β-selinene, cis, trans-α-farnesene, δ-cadinene, β-sesquiphellandrene, ar-curcumene), oxygenated sesquiterpenes (caryophyllene oxide, trans-nerolidol, globulol, guaiol, spathulenol, eugenol, α-cedrol, torreyol, T-muurolol, cis-trans-farnesol), and others (1,2,4 trimethylbenzene, n-hexanol, 1-octen-3-ol, tricosane, tetracosane). Steam distilled oil from the flowers, leaves and total aerial parts contained borneol, chrysanthenone and bornyl acetate as the major components (Stoianova-Ivanova et al. 1983).
A water-soluble neutral polysaccharide (CIP-C) was obtained from Chrysanthemum indicum (Jin et al. 2012). CIP-C was found to be a neutral branched heteropolysaccharide, mainly composed of D-Man, D-Glc and D-Gal, with a small quantity of D-Fuc, L-Ara and D-Xyl. The backbone of CIP-C was linked by β(or α)-d-1,4-Man, β-d-1,6-Glc and β-d-1,4-Gal. In addition,T-Araf,1,5-Araf and T-Gal,1,4-Gal,1,3,6-Gal,1,3,4,6-Gal may be linked as an arabinan branch and an AGI arabinogalactan branch.
Root Phytochemicals
Mineral elements found in the roots were K 15.84 mg/g, P 1.25 mg/g, Ca 10.10 mg/g, Mg 2.54 mg/g, Na 3.16 mg/g, Fe 3219.90 μg/g, Mn 144.33 μg/g, Zn 227.50 μg/g, Cu 64.60 μg/g and Mo 0.22 μg/g (Cui and Guo 2012).
Antioxidant Activity
The water extract of gamguk teas did not differ significantly in yield compared to methanol extracts and showed stronger antioxidant activity (Eom et al. 2008). Catechin contents in gamguk teas were 8–18 % of the extracts. Gamguk teas exhibited faster release of antioxidants, and the antioxidant activity was positively correlated with the thermal treatments. Gukhwacha was the best tea for rapid release (30 seconds) of antioxidants with the 50 °C treatment, whereas antioxidants in other teas were relatively slower.
Anticancer Activity
Chrysanthemum indicum extract inhibited proliferation of human hepatocellular carcinoma (HCC) MHCC97H cells in a time- and dose-dependent manner without cytotoxicity in rat hepatocytes and human endothelial cells (Li et al. 2009). The extract CIE exerted a significant apoptotic effect through a mitochondrial pathway and arrested the cell cycle by regulation of cell cycle-related proteins in MHCC97H cells without an effect on normal cells. Yuan et al. (2009) found that C. indicum extract was effective in attenuating the mitogenic effect of isoproterenol on both HepG2 and MHCC97H human hepatocellular carcinoma cells. The inhibitory effect of the extract was mediated by inhibiting the isoproterenol -induced activation of MAPK/ERK1/2 via beta2-AR in tumour cells. In further studies, they found that C. indicum ethanol extract reduced MHCC97H cell metastatic capability, in part at least, through decrease of the MMP-2 and MMP-expression with a simultaneous increase of the TIMP-1 and TIMP-2 expression thus restoring their balance in the cancer cells (Wang et al. 2010b). Five Chinese herbs (Curcuma wenyujin, Chrysanthemum indicum, Salvia chinensis, Ligusticum chuanxiong and Cassia tora) were found to sensitize resistant cancer cells at a nontoxic concentration (10 μg/ml) and markedly increased doxorubicin accumulation in multidrug-resistant human breast cancer MCF-7/ADR cells (Yang et al. 2011b). Fractions from CH2Cl2 extracts were more effective than fractions from ethyl acetate extracts. Fractions from Curcuma wenyujin and C. indicum exhibited significant effects in sensitization of these resistant MCF-7/ADR cancer cells at nontoxic concentration to doxorubicin and docetaxel (Yang et al. 2011a). All the fractions could enhance the apoptosis induced by doxorubicin in MCF-7/ADR cells and restore the effect of docetaxel on the induction of G2/M arrest in A549/Taxol cells. The fractions also had to induce S-phase arrest.
The methylene chloride fraction of C. indicum crude ethanol extract exhibited strong cytotoxic activity as compared with the other fractions and clearly suppressed constitutive STAT3 activation against both human prostate cancer DU145 and U266 cells, but not human breast cancer MDA-MB-231 cells (Kim et al. 2013). It was found that the fraction could induce apoptosis through inhibition of the JAK1/2 and STAT3 signaling pathways. Furthermore, the major components of the fraction were bioactive compounds such as sudachitin, hesperetin, chrysoeriol and acacetin. Sudachitin, chrysoeriol and acacetin also exerted significantly cytotoxicity, clearly suppressed constitutive STAT3 activation, and induced apoptosis, although hesperetin did not show any significant effect in DU145 cells.
Antimicrobial Activity
C. indicum essential oil exhibited antibacterial activities against both Staphylococcus aureus and Escherichia coli (Aridoğan et al. 2002). The antimicrobial activity of essential oils from air-dried and processed flowers was evaluated against 15 microorganisms including 3 yeasts (Zhu et al. 2005). The results showed that both essential oils possessed significant antimicrobial effect; however, some difference in antimicrobial activity between two oils was observed for several microorganisms, which was attributed to the variation in percentage of the components. Antibacterial activities of the essential oils were exhibited against Staphylococcus aureus and Escherichia coli. With higher percentage of camphor, the oil of the processed flowers exhibited, in many cases, greater bacteriostatic activity than that of the air-dried ones.
The essential oil of C. indicum exhibited moderate activities against most of tested streptococci species (Streptococcus pyogenes, S. mutans, S. sanguinis, S. sobrinus, S. ratii, S. creceti, S. anginosus, S. gordonii) (MICs, 0.2–0.8 mg/ml; MBCs, 0.4–1.6 mg/ml) (Jung 2009). The oil also showed a strong antimicrobial activity against obligate anaerobic bacteria: Fusobacterium nucleatum, Prevotella intermedia and Porphylomonas gingivalis (MICs, 0.1–0.2 mg/ml; MBCs, 0.2–0.8 mg/ml). The major components of the essential oil from C. indicum, terpinon-4-ol, borneol and β-caryophyllene, were indicated as stronger antibacterial activity than α-pinene, camphor and 1,8-cineole. In combination with the essential oil, the MICs/MBCs for ampicillin and gentamicin were reduced by ≥8-fold in tested some of oral bacteria and reference bacteria, suggesting a synergistic effect.
C. indicum leaf volatile oil exerted maximum antibacterial activity against Pseudomonas aeruginosa at a concentration of 1 %v/v followed by against Micrococcus luteus in comparison with erythromycin as standard antibacterial agent (Pradhan et al. 2011). The volatile oil also exhibited antifungal activity against Candida albicans at the same concentration of 1 %v/v, when compared with ketoconazole as standard antifungal agent.
Antiinflammatory Activity
The methanol extract and ethyl acetate-soluble portion from the flowers of Chrysanthemum indicum were found to show inhibitory activity against nitric oxide (NO) production in lipopolysaccharide-activated macrophages with potent inhibitory activity shown by the acetylenic compounds and flavonoids from the ethyl acetate-soluble portion (Yoshikawa et al. 2000). Two acetylenic compounds, cis-Spiroketalenolether polyyne and trans-spiroketalenolether polyyne, and two flavones, luteolin and eupatilin, were found to inhibit nitric oxide production in mouse peritoneal macrophages. Chrysanthemol, a trans-eudesmane-type sesquiterpene from Chrysanthemum indicum, also possessed antiinflammatory activity (Mou et al. 2001). Studies showed that the C. indicum inflorescence extract (butanol fraction) possessed antiinflammatory, humoral and cellular immunomodulatory and mononuclear phagocytic activities, probably due to the presence of flavonoids (Cheng et al. 2005). At a dose of 150 mg/kg, p.o., the butanol-soluble fraction exhibited significant inhibition of auricle edema in mice. Delayed-type hypersensitivity reaction induced by 2,4-dinitro-fluorobenzene was significantly enhanced by the butanol extract (150 and 300 mg/kg, p.o.) as was antibody generation by splenic cells of mice and IgG and IgM levels in mice sera in response to sheep red blood cells in cyclophosphamide-induced mice. Both these doses potentiated the function of the mononuclear phagocytic system in cyclophosphamide-induced mice.
Separate studies on synoviocytes isolated from the knee joints of rats showed that the total flavonoids of Chrysanthemum indicum (TFC) could induce synoviocytes apoptosis and suppress proliferation of synoviocytes in Freund’s complete adjuvant-induced arthritis rats (Chen et al. 2008). Further studies in adjuvant arthritis rat model showed that TFC inhibited the proliferation of synovial and induced the apoptosis of synovium and synoviocytes in-vivo in a dose-dependent way and thereby exerted therapeutical effect on rheumatoid arthritis (Xie et al. 2008). Total flavonoids of C. indicum extract showed significant therapeutical effect on adjuvant arthritis in adjuvant arthritis rats, and its mechanism was at least in part related to the antioxidant and immunoregulatory effects (Zhang et al. 2010b). The extract decreased the levels of MDA and NO and increased the activity of SOD in serum and supernatant of peritoneal macrophage. Also the suppressed lymphocyte proliferation and IL-2 production of splenic lymphocytes in AA rats were reversed by treatment with the extract.
Studies found 70 % ethanol extract from Chrysanthemum indicum to be an effective antiinflammatory agent in murine phorbol ester-induced dermatitis, suggesting that the extract may have therapeutic potential in a variety of immune-related cutaneous diseases (Lee et al. 2009). The extract caused substantial reductions in skin thickness and tissue weight, inflammatory cytokine production, neutrophil-mediated myeloperoxidase activity and various histopathological indicators. The extract was also effective at reducing inflammatory damage induced by chronic12-O-tetradecanoyl-phorbol-13-acetate (TPA). Further studies showed that the antiinflammatory properties of C. indicum ethanol flower extract in lipopolysaccharide-induced RAW 264.7 macrophages might result from the inhibition of inflammatory mediators, such as NO, prostaglandin E2 (PGE2), TNF-alpha (tumour necrosis factor alpha) and IL-1beta (interleukin-1beta), via suppression of mitogen-activated protein kinases (MAPKs) and NF-kappa B (nuclear factor kappa B)-dependent pathways (Cheon et al. 2009). The results indicated that the extract may have therapeutic potential in a variety of immune-related cutaneous diseases.
Studies showed that at 1, 10 and 100 μg C. indicum extract inhibited cell loss, decreased the reactive oxygen species production, regulated the Bax/Bcl-2 ratio, and inhibited poly (ADP-ribose) polymerase (PARP) proteolysis in 1-methyl-4-phenylpridinium ion (MPP(+))-induced SH-SY5Y cells (Kim et al. 2011a). Moreover, the extract suppressed the production of prostaglandin E(2,) expression of cyclooxygenase type-2 (COX-2), blocked IκB-α degradation and activation of NF-κB p65 in BV-2 cells in a dose-dependent manner. The activity of the extract might involve its inhibitory actions both on neuronal apoptosis and neuroinflammatory NF-κB/IκB-α signaling pathway. In-vitro studies found that 70 % ethanol extract of Chrysanthemum indicum strongly inhibited Epstein–Barr virus (EBV) latent infection membrane protein 1 (LMP1)-induced activation of NF-κB and the viability of EBV-transformed lymphoblastoid cell lines (Kim et al. 2012).
A traditional Chinese medicine (TCM) recipe named CPZ comprising extracts of Chrysanthemum indicum, Pogostemon cablin and Curcuma wenyujin was found to possess potent antiinflammatory activity, which was indicated to be closely associated with its upregulation on interleukin IL-1β and downregulation of prostaglandin E(2) in the edema paw tissue of rats (Su et al. 2012).
Hypouricemic Activity
In a study, a total of 122 traditional Chinese medicinal plants were selected according to the clinical efficacy and prescription frequency for the treatment of gout and other hyperuricemia-related disorders and were evaluated for inhibitory activity of the xanthine oxidase enzyme that catalyses the oxidation of hypoxanthine to xanthine and then to uric acid, which plays a crucial role in gout (Kong et al. 2000). The methanol extract of C. indicum exhibited inhibitory effect on xanthine oxidase activity with an IC50 of 22 μg/ml and ranked second to Cinnamomum cassia twig (IC50 18 μg/ml) thus providing a basis for the use of this medicinal plant for gout treatment.
Hemodynamic/Cardiovascular Activity
An aqueous extract of Chrysanthemum indicum flower directly and uniformly produced coronary and systemic vasodilation action and a renal vasoconstricting action in the open-chest dog, and the pharmacological profile of the flower extract was in part similar to that of adenosine (Kato et al. 1986). Intravenous administration of the aqueous extract (5–20 mg/kg) produced a decrease in aortic blood pressure and increases in coronary blood flow, left ventricular dP/dt (change in pressure/change in time) and heart rate in a dose-dependent manner, while renal blood flow was initially decreased and then increased to the values above the preinjection level. Dipyridamole (0.1 mg/kg i.v.) potentiated an increase in coronary blood flow of the extract and aminophylline (1.0 mg/kg i.v.) attenuated this response. A two-fold increase in coronary blood flow was elicited by the aqueous extract (13.8 mg/kg) and by adenosine (29.5 μg/kg). Intravenous administration of the flower extract (5–20 mg/kg) as well as adenosine (10–50 μg/kg) produced decreases in aortic blood pressure and renal blood flow and increases in aortic blood flow, vertebral blood flow, coronary blood flow and left ventricular dP/dt (Kato et al. 1987). Calculated coronary, vertebral and total peripheral resistances were decreased by the extract or adenosine in a dose-dependent manner. The results indicated that C. indicum extract directly and uniformly produced coronary and systemic vasodilation with renal vasoconstriction and that adenosine directly produced vasoconstriction in renal vasculature and vasodilation which was more potent in coronary vasculature than in systemic ones.
Sun et al. (2012) found that flavonoids, namely, (2S)-eriodict-dicaffeoylquinate; 3,5-dicaffeoylquinic acid; 3,5-cis-dicaffeoylquinic acid; 1,5-dicaffeoylquinic acid; and 1,3-dicaffeoylquinic acid, were the major components of the active fraction of C. indicum that exhibited cardiovascular activity.
Antidiabetic and Antiaging Activities
In bovine serum albumin (BSA)/glucose (fructose) systems, both C. morifolium and C. indicum strongly inhibited the formation of advanced glycation end products (AGEs) and N ε-(carboxymethyl)lysine (Tsuji-Naito et al. 2009). C. morifolium, not C. indicum, also inhibited the formation of fluorescent AGEs, including pentosidine. C. morifolium was found to have high amounts of chlorogenic acid, flavonoid glucosides (including acetyl glucoside, neohesperiidoside), and apigenin, while C. indicum contained large amounts of caffeic acid, luteolin and kaempferol. The results suggested the potential of both Chrysanthemum species for the successful treatment of conditions associated with diabetic complications and aging.
Aldose Reductase Inhibitory Activity
Two new flavanone glycosides, (2S)-eriodictyol 7-O-β-d-glucopyranosiduronic acid (1) and (2R)-eriodictyol 7-O-β-d-glucopyranosiduronic acids (2), and a new phenylbutanoid glycoside, (2S, 3S)-1-phenyl-2,3-butanediol 3-O-β-d-glucopyranoside, were isolated from Chrysanthemum indicum flowers, and (1) and (2) exhibited potent inhibitory activity for rat lens aldose reductase (Matsuda et al. 2002). However, the inhibitory activities of 1 and 2 were weaker than those of luteolin and luteolin 7-O-β-d-glucopyranoside which were also isolated from the flowers of C. indicum by Yoshikawa et al. (1999). Aldose reductase is a key enzyme in the polyol pathway that catalyses the reduction of glucose to sorbitol. Accumulation of sorbitol has been implicated in the chronic complications of diabetes such as cataract. The methanol extract of the flower extract exhibited inhibitory activity against rat lens aldose reductase (Yoshikawa et al. 1999). From the methanol flower extract, active components such as flavone and flavone glycosides were isolated by bioassay-guided separation using aldose reductase inhibitory activity together with three new eudesmane-type sesquiterpenes called kikkanols A, B and C. The flavone, luteolin, three flavone glycosides (luteolin 7-O-β-d-glucopyranoside, luteolin 7-O-β-d-glucopyranosiduronic acid, acacetin 7-O-(60-α-l-rhamnopyranosyl)-β-d-glucopyranoside), and chlorogenic acid were potent inhibitors of rat lens aldose reductase, but their activity was weaker than that of a commercial synthetic aldose reductase inhibitor, epalrestat. Another flavone, eupatilin, and two sesquiterpenes (clovanediol, caryolane 1,9β-diol) exhibited less activity than luteolin and the three flavone glycosides. Other sesquiterpenes (kikkanol A, kikkanol C, oplopanone) and two polyacetylenes (cis-spiroketalnenolether polyyne, trans-spiroketalenolether polyyne) exhibited little activity.
Antidermatitis Activity
Topical application Chrysanthemum indicum to mice with atopic dermatitis-like skin lesions in 2,4-dinitrochlorobenzene (DNCB)-treated NC/Nga mice dose dependently reduced severity of clinical symptoms of dorsal skin, ear thickness and the number of mast cells and eosinophils (Park et al. 2012). C. indicum (30 %) significantly decreased serum IgE, IgG1, IL-4 and IFN-γ levels and reduced mRNA levels of interferon IFN-γ, interleukins IL-4 and IL-13 in dorsal skin lesion. The results suggested that C. indicum may be an effective alternative for the management of atopic dermatitis.
Nephroprotective Activity
Chrysanthemum indicum extract protected human proximal tubular HK-2 cells against cisplatin-induced apoptosis by its antioxidant activity against hydrogen peroxide and hydroxyl radical (Pongjit et al. 2011). In addition, the extract renal cells without significant interfering effect on cisplatin toxicity in lung cancer H460 and melanoma G361 cells.
Neuroprotective Activity
Chrysanthemum indicum was found to possess neuroprotective activity (Chun et al. 2008). It had been recorded as having therapeutic effects for stroke in Korean traditional medicine. Its aqueous extract significantly increased the cell viability of SK-N-SH human neuroblastoma cells exposed to oxygen–glucose deprivation both in-vitro and in-vivo cerebral ischemia models.
Radioprotective Activity
Chrysanthemum indicum flowers were reported being able to absorb ultraviolet and cure sunburn (Huang et al. 2004). It has potential to be a natural additive in health protection cosmetic.
Hepatoprotective Activity
Chrysanthemum indicum was one of the nine Chinese herbal medicine with hepatoprotective and antioxidant activity, inhibiting lipid peroxidation in a dose-dependent manner thereby protecting liver function (Jiang et al. 1997).
Antithrombotic Activity
Studies by Levy and Xie (1988) reported that the aqueous extract of Chrysanthemum indicum flowers was 10–12 times more potent on platelet-activating factor (PAF)-induced aggregation of human platelet-rich plasma compared to ADP (adenosine diphosphate) aggregation of rat platelet-rich plasma providing partial evidence in support of the traditional use of Chrysanthemum indicum in the treatment or prevention of thrombosis.
Cardioprotective Activity
Li (1981) reported that C. indicum extract protected injured neonatal rat heart cells by reducing the release of lactate dehydrogenase (LDH) from injured heart cells deprived of oxygen and glucose. Further 10−5 M propranolol showed similar protective effect, while 10−4 M isoprenaline exacerbated heart cell injury.
Chrysanthemum indicum flower (FCI), Chrysanthemum morifolium flower (FCM) and Salvia miltiorrhiza root (RSM) extracts were found to be efficient in ameliorating the extent and severity of the lesion in experimental myocardial infarction in the dog (Chen et al. 1983). FCI gave the best results. Experimental coronary insufficiency was also improved both in extent and severity by treating with FCI in moderate dose and with FCM, SMB and FCI in large dose. In another study, after 7–9 days of treatment, C. indicum significantly reduced the left ventricular weight index and heart weight index in mice and rats with myocardial hypertrophy induced by isoprenaline and l-thyroxine, decreased the content of angiotensin II in ventricular tissue in mice and rats, and reduced the ALD, TNF-alpha concentration in serum, and the hydroxy proline content in ventricular tissue in rats (Wu et al. 2010b).
Antihypertensive Activity
An active fraction from the hot ethanol extract of C. indicum was found to lower blood pressure in anaesthetized cats and normotensive dogs (Liu et al. 1962). Four normotensive dogs fed 50, 100, 130 and 150 mg/kg of the fraction, registered diastolic pressure decline of 0, 24, 8 and 36 mmHg, respectively. Weekly tests on EKG (electrocardiogram), serum BSP (bone sialoprotein) retention and blood NPN (nonprotein nitrogen) revealed no serious alterations when three renal hypertensive dogs were fed daily 100 mg/kg in the first 2 weeks and 200 mg/kg for the third week.
Antinociceptive/Analgesic Activity
The petroleum ether fraction from the ethanol extract of flowers and buds administered orally at doses of 188 and 376 mg/kg to mice produced significant inhibitions on chemical nociception induced by intraperitoneal acetic acid, subplantar formalin or capsaicin injections and on thermal nociception in the tail-flick test and the hot plate test (Shi et al. 2011). In the pentobarbital sodium-induced sleep time test and the open-field test, the flower fraction neither enhanced the pentobarbital sodium-induced sleep time nor impaired the motor performance, indicating that the observed antinociception was unrelated to sedation or motor abnormality. The fraction did not affect temperature within 80 minutes. The results suggested that petroleum ether flower fraction-produced antinociception might involved ATP-sensitive K+ channels and the mAChRs-ATP-sensitive K+ channels pathway. The aqueous fraction of an ethanol C. indicum extract administered orally to mice produced analgesic activity in the chemical nociception induced by intraperitoneal acetic acid, subplantar formalin/capsaicin injections model and in the thermal nociception in the tail-flick test and in the hot plate test (Chen et al. 2011). In the pentobarbital sodium-induced sleeping time test and the open-field test, the aqueous fraction neither significantly enhanced the pentobarbital sodium-induced sleeping time nor impaired the motor performance, indicating that the observed analgesic activity was unlikely due to sedation or motor abnormality. Moreover, the effective dose (600 mg/kg) also showed no toxicity within 7 days. The results suggested the analgesic activity possibly related to the flavonoid glycosides and phenolic glycosides in the fraction.
Otoprotective Activity
Studies found that Chungshinchongyitang (CSCYT), an herbal drug formula containing Chrysanthemum indicum and 13 other herbs, prevented the destruction of hair cell arrays induced by cadmium in the rat organ of Corti primary explants (Kim et al. 2011b). CSCYT inhibited cell death, release of cytochrome C, and generation of reactive oxygen species induced by cadmium in HEI-OC1 auditory cell line. Further, it was demonstrated that CSCYT exerted its effect by modulating apoptosis via the caspase-3 activation and extracellular signal-regulated kinase activation. CSCYT is used in Korean medicine for treating auditory diseases.
Antiosteoporotic Activity
Gamuk flower oil was found to increase the collagen, alkaline phosphatase activity and mineralization of osteoblasts (MC3T3-E1 cells) significantly, indicating that ‘gamguk’ may help in the treatment of osteoporosis (Chang et al. 2010). Chrysanthemum indicum extract (100 μg/ml) significantly increased the growth of osteoblastic MC3T3-E1 cells and caused a significant elevation of alkaline phosphatase (ALP) activity and the deposition of collagen and calcium in the cells (Yun et al. 2011). This activity was completely prevented by the presence of 1 μM tamoxifen, suggesting that the extract’s effect might be partly involved in estrogen-related activities. The results indicated that the enhancement of osteoblast functionality by C. indicum may prevent osteoporosis and inflammatory bone diseases.
Antidiabetic and Antiaging Activities
In bovine serum albumin (BSA)/glucose (fructose) systems, both C. morifolium and C. indicum strongly inhibited the formation of advanced glycation end products (AGEs) and N ε-(carboxymethyl)lysine (Kentaro et al. 2009). C. morifolium, not C. indicum, also acted to inhibit the formation of fluorescent AGEs, including pentosidine. C. morifolium was found to large amounts of chlorogenic acid, flavonoid glucoside varieties and apigenin, while C. indicum contained large amounts of caffeic acid, luteolin and kaempferol. The results suggested the potential of both Chrysanthemum species for the successful treatment of pathogenesis in conditions associated with diabetic complications and aging.
Antiplasmodial Activity
The leaf extracts of Aristolochia indica (IC50 10 μg/ml), Cassia auriculata (IC50 14 μg/ml), Chrysanthemum indicum (IC50 20 μg/ml) and Dolichos biflorus (IC50 20 μg/ml) showed promising activity against blood stage chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum (Kamaraj et al. 2012). The high TC50 in mammalian cell cytotoxicity assay and the low IC50 in antimalarial P. falciparum assay indicated selectivity and good resistance indices in the range of 0.9–1.7 for leaf extracts of A. indica, C. auriculata, C. indicum and D. biflorus, suggesting that these may serve as antimalarial agents even in their crude form.
Larvicidal Activity
Among three plant extracts (Annona squamosa, Chrysanthemum indicum and Tridax procumbens) tested, the ethyl acetate leaf extract of C. indicum exhibited highest toxic effect (LC50 = 39.98 mg/l) against larvae of malaria vector, Anopheles subpictus and the methanol leaf extract against the larvae of Japanese encephalitis vector, Culex tritaeniorhynchus (LC50 = 42.29 mg/l) (Kamaraj et al. 2011).
Allergy Problem
Of 12 fractions obtained from C. indicum dried flower extract, four fractions gave on epicutaneous application to guinea pigs sensitized with an extract of C. indicum (Hausen and Schulz 1976). One of these allergens was identified as a sesquiterpene lactone, Arteglasin-A of the guaianolide-type.
Traditional Medicinal Uses
C. indicum has a long history of use as an Oriental traditional medicine for the treatment of several infectious diseases such as pneumonia, colitis, stomatitis, cancer, fever and sores and used to treat vertigo, pertussis, inflammatory diseases, intoxication, respiratory ailments, hypertension and hypotensive symptoms (Stuart 1979; Duke and Ayensu 1985; Yeung 1985; Yu et al. 1992; Jiang et al. 1997; Corlett et al. 2002; Matsuda et al. 2002; Cheng et al. 2005; Zhu et al. 2005; Morikawa 2007; Chun et al. 2008; Chen et al. 2008; Cheon et al. 2009; Jin et al. 2012). Various parts of the plant have been used in traditional medicine in India and Southeast Asia (CSIR 1950; Burkill 1966; Kirtikar and Basu 1975; Chopra et al. 1986; Le and Nguyen 1999; Stuart 2012). In traditional Chinese medicine, the whole plant is antiphlogistic, blood tonic, aperient, antipyretic, depurative, febrifuge and vulnerary, and the plant is used to treat eye ailments. Chrysanthemum indicum is a common traditional herbal medicine used for the treatment of inflammation, hypertension and respiratory diseases due to its strong antagonistic function against inflammatory cytokines (Yun et al. 2011). In India, the plant is used in conjunction with black pepper for treating gonorrhoea and affections of the brain, calculi, as well as antidote for mental depression. The plant is used in ointments used for bruises, sprains and calluses. In Malaya, the plant is used for colds and headaches and as a poultice for sores and infused in spirits as a digestive. The entire plant or flower is used for whooping cough.
The flowers are aperient, bitter, hypotensive, stomachic and vasodilatory. The flowers of C. indicum and C. morifolium (Kangiku) are listed in Japanese pharmacopeia as treatments of cephalalgia, vertigo and eye inflammation. The flowers of C. indicum is prescribed for antiinflammatory, hypertension, analgesic and antipyretic purposes and the treatment of eye disease in Chinese traditional preparations. In Vietnam, the flowers are employed to treat cold, fever, photopsia, vertigo, headache, ophthalmia, dacryolithiasis, xerophthalmia, amblyopia, hypertension, boils, furunculus and phlegmon. Long-term use is beneficial for qi and blood and rejuvenating. Flowers are externally applied as lotion or poultice to cure furunculosis. The flowers are used in the treatment of furuncle; scrofula; deep-rooted boils; mammary carbuncles; inflammation of the throat, eyes and cervix; eczema; and itchiness of the skin. The flowers are used as general tonic and to alleviate cough as well as externally to reduce bruising by the Hmong group of Vietnam. Emulsion of flowers is used for infections of the cervix; infusion of the flowering heads is used as carminative, and flowers are also burnt as insect repellent. In India, the flowers are employed as a stomachic and laxative. In Malaya, the flowers are used for sore eyes. In Guam, infusion of flowers is used as remedy for intermittent fevers and also used by women as remedy for hysteria and menstrual problems.
The leaves are depurative and used for migraine in Indochina and China.
Other Uses
Indian chrysanthemum is also widely cultivated as an ornamental. In China, it is used as a source of oil and source of nectar for bees.
Comments
Chrysanthemum indicum is one of the main parents of the florists’ chrysanthemum (Chrysanthemum morifolium).
Selected References
Aridoğan BC, Baydar H, Kaya S, Demirci M, Ozbasar D, Mumcu E (2002) Antimicrobial activity and chemical composition of some essential oils. Arch Pharm Res 25(6):860–864
Burkill IH (1966) A dictionary of the economic products of the Malay Peninsula, revised reprint, 2 vols. Ministry of Agriculture and Co-operatives, Kuala Lumpur, vol 1 (A–H), pp 1–1240, vol 2 (I–Z), pp 1241–2444
Chang KM, Kim GH (2008) Volatile aroma composition of Chrysanthemum indicum L. flower oil. J Food Sci Nutr 13(2):122–127
Chang KM, Kim GH (2009) Comparative chemical composition of domestic and imported Chrysanthemum indicum L. flower oils. Food Sci Biotechnol 18(5):1288–1292
Chang KM, Cho EM, Kim GH (2010) Chemical constituents of Chrysanthemum indicum L. flower oil and effect on osteoblastic MC3T3-E1 cells. Food Sci Biotechnol 19(3):815–819
Chen ZN, Xu PJ (1987) Structural determination of yejuhua lactone, isolated from Chrysanthemum indicum L. Yao Xue Xue Bao 22(1):67–69 (in Chinese)
Chen KY, Wen SF, Zhi ZJ, Shao JS (1983) Preliminary observation of 131Cs distribution in experimental acute myocardial infarction and coronary insufficiency treated with root of Salvia miltiorrhiza, flower of Chrysanthemum morifolium and Chrysanthemum indicum. J Tradit Chin Med 3(4):265–270 (in Chinese)
Chen XY, Li J, Cheng WM, Jiang H, Xie XF, Hu R (2008) Effect of total flavonoids of Chrysanthemum indicum on the apoptosis of synoviocytes in joint of adjuvant arthritis rats. Am J Chin Med 36(4):695–704
Chen YF, Zhao MH, Yan M, Shi GB, Hou GX, Huang Y, Wang X, Zhao QC (2011) Analgesic activity of the aqueous fraction from the ethanolic extract of Chrysanthemum indicum in mice. Pharmazie 66(7):538–542
Cheng ZX, Chien MK, Tseng KF (1962) Studies on the flavonoids present in chinese drugs. VIII. Studies on the component of ye-ju-hua, the dry flower of Chrysanthemum indicum L. Yao Xue Xue Bao 13:370–374
Cheng WM, Li J, You TP, Hu CM (2005) Anti-inflammatory and immunomodulatory activities of the extracts from the inflorescence of Chrysanthemum indicum Linné. J Ethnopharmacol 101(1–3):334–337
Cheon MS, Yoon T, Lee DY, Choi G, Moon BC, Lee AY, Choo BK, Kim HK (2009) Chrysanthemum indicum Linne extract inhibits the inflammatory response by suppressing NF-kappaB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophages. J Ethnopharmacol 122(3):473–477
Choi HS, Kim GH (2011) Volatile flavor composition of gamguk (Chrysanthemum indicum) flower essential oils. Food Sci Biotechnol 20(2):319–325
Chopra RN, Nayar SL, Chopra IC (1986) Glossary of Indian medicinal plants (Including the supplement). Council Scientific Industrial Research, New Delhi, 330pp
Chun HS, Kim JM, Choi EH, Chang N (2008) Neuroprotective effects of several Korean medicinal plants traditionally used for stroke remedy. J Med Food 11(2):246–251
Corlett JL, Clegg MS, Keen CL, Grivetti LE (2002) Mineral content of culinary and medicinal plants cultivated by Hmong refugees living in Sacramento, California. Int J Food Sci Nutr 53:17–128
Council of Scientific and Industrial Research (CSIR) (1950) The wealth of India. A dictionary of Indian raw materials and industrial products (Raw materials 2). Publications and Information Directorate, New Delhi
Cui XS, Guo YH (2012) Analysis of mineral elements in different organs of Chrysanthemum indicum L. based on ICP-AES. Guang Pu Xue Yu Guang Pu Fen Xi 32(10):2828–2830 (in Chinese)
Duke JA, Ayensu ES (1985) Medicinal plants of China, vols 1 and 2. Reference Publications, Inc., Algonac, 705pp
Eom SH, Park HJ, Jin CW, Kim DO, Seo DW, Jeong YH, Cho DH (2008) Changes in antioxidant activity with temperature and time in Chrysanthemum indicum L. (gamguk) teas during elution processes in hot water. Food Sci Biotechnol 17(2):408–412
Facciola S (1990) Cornucopia. A source book of edible plants. Kampong Publications, Vista, 677pp
Feng Z, Yang Y, Jiang J, Zhang P (2010) Chemical constituents from flowers of Chrysanthemum indicum. Zhongguo Zhong Yao Za Zhi 35(24):3302–3305 (in Chinese)
Flann C (ed) (2009+) Global Compositae checklist. Accessed 11 Dec 2012
Gao MH, Li H, Zhang L, Xiao SX (2008) Studies on chemical constituents from flowers of Chrysanthemum indicum. Zhong Yao Cai 31(5):682–684 (in Chinese)
Hausen BM, Schulz KH (1976) Chrysanthemum allergy III. Identification of the allergens. Arch Dermatol Res 255(2):111–121
Hausen BM, Schulz KH, Jarchow O, Klaska KH, Schmalle H (1975) A first allergenic sesquiterpene lactone from Chrysanthemum indicum L.: arteglasin-A. Naturwissenschaften 62(12):585–586
Huang YP, Ling YR (1996) Economic compositae in China (pp 431–451). In: Caligari PDS, Hind DJN (eds) Compositae: biology and utilization. Proceedings of the international Compositae conference, Kew, Royal Bot. Gardens, Kew, 689pp
Huang C, Ouyang YD, Fang YW, Yu YP, Lin SH (2004) Study on spectral properties of Chinese herbal medicines additives in cosmetic. Guang Pu Xue Yu Guang Pu Fen Xi 24(12):1649–1651 (in Chinese)
Jiang H, Huang X, Yang Y, Zhang Q (1997) Studies on the antilipid peroxidation of nine sorts of Chinese herbal medicines with the function of protecting liver. Zhong Yao Cai 20(12):624–626 (in Chinese)
Jin HY, Shi SS, Wang SC, Wang ZT, Hu ZB (2012) Isolation and structural characterization of a new neutral polysaccharide from Chrysanthemum indicum L. Chem J Chin Univ 33(4):755–760
Jung EK (2009) Chemical composition and antimicrobial activity of the essential oil of Chrysanthemum indicum against oral bacteria. J Bacteriol Virol 39(2):61–69
Kamaraj C, Bagavan A, Elango G, Zahir AA, Rajakumar G, Marimuthu S, Santhoshkumar T, Rahuman AA (2011) Larvicidal activity of medicinal plant extracts against Anopheles subpictus & Culex tritaeniorhynchus. Indian J Med Res 134:101–106
Kamaraj C, Kaushik NK, Mohanakrishnan D, Elango G, Bagavan A, Zahir AA, Rahuman AA, Sahal D (2012) Antiplasmodial potential of medicinal plant extracts from Malaiyur and Javadhu hills of South India. Parasitol Res 111(2):703–715
Kato T, Noguchi K, Sakanashi M, Miyamoto Y, Suekawa M, Aburada M, Hosoya E (1986) Effects of the water extract of Chrysanthemum indicum Linn. on coronary and systemic hemodynamics in the dog. Arch Int Pharmacodyn Ther 280(2):241–253
Kato T, Noguchi K, Miyamoto Y, Suekawa M, Aburada M, Hosoya E, Sakanashi M (1987) Effects of Chrysanthemum indicum Linn. on coronary, vertebral, renal and aortic blood flows of the anesthetized dog. Arch Int Pharmacodyn Ther 285(2):288–300
Kentaro TN, Hiroshi S, Miyaki H (2009) Inhibitory effects of Chrysanthemum species extracts on formation of advanced glycation end products. Food Chem 116:854–859
Kim DK, Lee KD (2009) Effects of nitrogen application on growth and bioactive compounds of Chrysanthemum indicum L. (Gamgug). Kor J Med Crop Sci 17(5):363–368
Kim IS, Ko HM, Koppula S, Kim BW, Choi DK (2011a) Protective effect of Chrysanthemum indicum Linne against 1-methyl-4-phenylpridinium ion and lipopolysaccharide-induced cytotoxicity in cellular model of Parkinson’s disease. Food Chem Toxicol 49(4):963–973
Kim SJ, Myung NY, Shin BG, Lee JH, So HS, Park RK, Um JY, Hong SH (2011b) Protective effect of a Chrysanthemum indicum containing formulation in cadmium-induced ototoxicity. Am J Chin Med 39(3):587–600
Kim JE, Jun S, Song M, Kim JH, Song YJ (2012) The extract of Chrysanthemum indicum Linne inhibits EBV LMP1-induced NF-κB activation and the viability of EBV-transformed lymphoblastoid cell lines. Food Chem Toxicol 50(5):1524–1528
Kim C, Kim MC, Kim SM, Nam D, Choi SH, Kim SH, Ahn KS, Lee EH, Jung SH, Ahn KS (2013) Apoptosis through suppression of constitutive STAT3 activation in human prostate cancer DU145 Cells. Phytother Res 27(1):30–38
Kirtikar KR, Basu BD (1975) Indian medicinal plants, 4 vols, 2nd ed. Jayyed Press, New Delhi
Kong LD, Cai Y, Huang WW, Cheng CH, Tan RX (2000) Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J Ethnopharmacol 73(1–2):199–207
Le VT, Nguyen GC (eds) (1999) Selected medicinal plants in Vietnam, vol 1. National Institute of Materia Medica Science and Technology Publishing House, Hanoi, 439pp
Lee DY, Choi G, Yoon T, Cheon MS, Choo BK, Kim HK (2009) Anti-inflammatory activity of Chrysanthemum indicum extract in acute and chronic cutaneous inflammation. J Ethnopharmacol 123(1):149–154
Levy JV, Xie ZF (1988) Effect of three Chinese herbal medicines (Ligustrazine, Chrysanthemum indicum, Salviae miltiorrhizae) on PAF and ADP-induced platelet aggregation in vitro. Prostaglandins 35(5):842
Li YO (1981) Protective effect of Chrysanthemum indicum L extract (CI-2) on myocardial injury in cultured neonatal rat heart cells deprived of oxygen and glucose. Zhong Xi Yi Jie He Za Zhi 1(2):93–97 (in Chinese)
Li ZF, Wang ZD, Ji YY, Zhang S, Huang C, Li J, Xia XM (2009) Induction of apoptosis and cell cycle arrest in human HCC MHCC97H cells with Chrysanthemum indicum extract. World J Gastroenterol 15(36):4538–4546
Liu JF, Chu CC, Chien MK, Ting KS (1962) Studies on antihypertensive drugs. XIII. Experimental therapy and toxicity of HC-1, an extract from Chrysanthemum indicum. Yao Xue Xue Bao 9(3):151–154 (in Chinese)
Liu LL, Wang R, Shi YP (2011) Chrysindins A-D, polyacetylenes from the flowers of Chrysanthemum indicum. Planta Med 77(16):1806–1810
Lu JQ, Wan W, Xu YT, Zhan XL, He XF, Cao RB, Wu DH, Hu XY (2009) Studies on chemical constituents of Dendranthema indicum var. aromaticum. Zhong Yao Cai 32(1):53–55 (in Chinese)
Matsuda H, Morikawa T, Toguchida I, Harima S, Yoshikawa M (2002) Medicinal flowers. VI. Absolute stereostructures of two new flavanone glycosides and a phenylbutanoid glycoside from the flowers of Chrysanthemum indicum L.: their inhibitory activities for rat lens aldose reductase. Chem Pharm Bull(Tokyo) 50(7):972–975
Mladenova K, Tsankova E, Kostova I, Stoianova-Ivanova B (1987) Indicumenone, a new bisabolane ketodiol from Chrysanthemum indicum. Planta Med 53(1):118–119
Mladenova K, Tsankova E, Dinh VH (1988) New sesquiterpenoids from Chrysanthemum indicum var. tuneful. Planta Med 54(6):553–555
Morikawa T (2007) Search for bioactive constituents from several medicinal foods: hepatoprotective, antidiabetic, and antiallergic activities. J Nat Med 61(2):112–116
Mou LY, Zhu LY, Lin ZY, Liang XT (2001) Stereoselective total synthesis of chrysanthemol. J Asian Nat Prod Res 3(2):103–116
Park S, Lee JB, Kang S (2012) Topical application of Chrysanthemum indicum L. attenuates the development of atopic dermatitis-like skin lesions by suppressing serum IgE levels, IFN-γ, and IL-4 in Nc/Nga mice. Evid Based Complement Alternate Med 2012:821967
Pongjit K, Ninsontia C, Chaotham C, Chanvorachote P (2011) Protective effect of Glycine max and Chrysanthemum indicum extracts against cisplatin-induced renal epithelial cell death. Hum Exp Toxicol 30(12):1931–1944
Pradhan CK, Katara A, Singh P, Mishra G, Khosa RL (2011) Chemical characterization by GLC & GC-MS and antimicrobial activity of essential oil from leaves of Chrysanthemum indicum Linn. Int J Pharm Tech Res 3(1):175–179
Schmelzer GH (2001) Dendranthema indicum (L.) Des Moul. In: van Valkenburg JLCH, Bunyapraphatsara N (eds) Plant resources of South-East Asia no. 12(2): medicinal and poisonous plants 2. Backhuys Publisher, Leiden, pp 212–213
Shi GB, Zhao MH, Zhao QC, Huang Y, Chen YF (2011) Mechanisms involved in the antinociception of petroleum ether fraction from the EtOH extract of Chrysanthemum indicum in mice. Phytomedicine 18(7):609–616
Stoianova-Ivanova B, Budzikiewicz H, Koumanova B, Tsoutsoulova A, Mladenova K, Brauner A (1983) Essential oil of Chrysanthemum indicum. Planta Med 49(12):236–239
Stuart RGA (1979) Chinese Materia Medica: vegetable kingdom. Southern Materials Centre Inc, Taipei
Stuart GU (2012) Philippine alternative medicine. Manual of some Philippine medicinal plants. http://www.stuartxchange.org/OtherHerbals.html. Accessed Mar 2012
Su JY, Tan LR, Lai P, Liang HC, Qin Z, Ye MR, Lai XP, Su ZR (2012) Experimental study on anti-inflammatory activity of a TCM recipe consisting of the supercritical fluid CO2 extract of Chrysanthemum indicum, patchouli oil and zedoary turmeric oil in vivo. J Ethnopharmacol 141(2):608–614
Sun Y, Ma X, Liu J (2012) Compounds from fraction with cardiovascular activity of Chrysanthemum indicum. Zhongguo Zhong Yao Za Zhi 37(1):61–65
Tang Y, Gao MH, Yao MC (2009) Studies on the flavones from flos Chrysanthemi indici. Zhong Yao Cai 32(10):1532–1534
Tsuji-Naito K, Saeki H, Hamano M (2009) Inhibitory effects of Chrysanthemum species extracts on formation of advanced glycation end products. Food Chem 116:854–859
Uchio Y, Tomosue K, Nakayama M, Yamammura A, Waki T (1981) Constituents of the essential oil from three tetraploid species of Chrysanthemum. Phytochemistry 20(12):2691–2693
Uphof JCT (1968) Dictionary of economic plants, 2nd ed (1st ed. 1959). Cramer, Lehre, 591pp
Usher G (1974) A dictionary of plants used by man. Constable, London, 619pp
Wang XL, Peng SL, Liang J, Yu KB (2006) (3β,5α,6β,7β,14β)-eudesmen-3,5,6,11-tetrol methanol solvate: a new sesquiterpenoid from Chrysanthemum indicum L. Acta Crystallogr Sect E Struct Rep Online 62(8):o3570–o3571
Wang J, Chen D, Liang L, Xue P, Tu P (2010a) Chemical constituents from flowers of Chrysanthemum indicum. Zhongguo Zhong Yao Za Zhi 35(6):718–721 (in Chinese)
Wang ZD, Huang C, Li ZF, Yang J, Li BH, Liang RR, Dai ZJ, Liu ZW (2010b) Chrysanthemum indicum ethanolic extract inhibits invasion of hepatocellular carcinoma via regulation of MMP/TIMP balance as therapeutic target. Oncol Rep 23(2):413–421
Wang JS, Zhou J, Kong LY (2012) Three new germacrane-type sesquiterpene stereoisomers from the flowers of Chrysanthemum indicum. Fitoterapia 83(8):1675–1679
Wu LY, Gao HZ, Wang XL, Ye JH, Lu JL, Liang YR (2010a) Analysis of chemical composition of Chrysanthemum indicum flowers by GC/MS and HPLC. J Med Plant Res 4(5):421–426
Wu Q, Chen CX, Gu WL, Gao JP, Wan Y, Lv J (2010b) Effect of Chrysanthemum indicum on ventricular remodeling in rats. Zhong Yao Cai 33(7):1112–1115 (in Chinese)
Xie XF, Li J, Chen Z, Hu CM, Chen WW (2008) Beneficial effect of total flavonoids of Chrysanthemum indicum on adjuvant arthritis by induction of apoptosis of synovial fibroblasts. Zhongguo Zhong Yao Za Zhi 33(23):2838–2841 (in Chinese)
Yang L, Wei DD, Chen Z, Wang JS, Kong LY (2011a) Reversal of multidrug resistance in human breast cancer cells by Curcuma wenyujin and Chrysanthemum indicum. Phytomedicine 18(8–9):710–718
Yang L, Wei DD, Chen Z, Wang JS, Kong LY (2011b) Reversal effects of traditional Chinese herbs on multidrug resistance in cancer cells. Nat Prod Res 25(19):1885–1889
Yeung HC (1985) Handbook of Chinese herbs and formulas, 2nd edn. Redwing Book, Brookline, 431pp
Yoshikawa M, Morikawa T, Murakami T, Toguchida I, Harima S, Matsuda H (1999) Medicinal flowers. I. Aldose reductase inhibitors and three new eudesmane-type sesquiterpenes, kikkanols A, B, and C, from the flowers of Chrysanthemum indicum L. Chem Pharm Bull(Tokyo) 47(3):340–345
Yoshikawa M, Morikawa T, Toguchida I, Harima S, Matsuda H (2000) Medicinal flowers. II. Inhibitors of nitric oxide production and absolute stereostructures of five new germacrane-type sesquiterpenes, kikkanols D, D monoacetate, E, F, and F monoacetate from the flowers of Chrysanthemum indicum L. Chem Pharm Bull(Tokyo) 48(5):651–656
Yu DQ, Xie FZ, He WY, Liang XT (1992) Application of 2D NMR techniques in the structure determination of chrysanthetriol. Yao Xue Xue Bao 27(3):191–196 (in Chinese)
Yuan A, Li Z, Li X, Yi S, Wang S, Shi K, Bian J (2009) Distinct effect of Chrysanthemum indicum Linné extracts on isoproterenol-induced growth of human hepatocellular carcinoma cells. Oncol Rep 22(6):1357–1363
Yun JH, Hwang ES, Kim GH (2011) Effects of Chrysanthemum indicum L. extract on the growth and differentiation of osteoblastic MC3T3-E1 Cells. J Kor Soc Food Sci Nutr 40(10):1384–1390
Zhang C, Qin MJ, Shu P, Hong JL, Lü L, He DX (2010a) Chemical variations of the essential oils in flower heads of Chrysanthemum indicum L. from China. Chem Biodivers 7(12):2951–2962
Zhang J, Zhang L, Li J, Cheng W, Peng L, Zhang Q (2010b) Effects of total flavonoids of Chrysanthemum indicum on free radical in adjuvant arthritic rats. Zhongguo Zhong Yao Za Zhi 35(3):344–347 (in Chinese)
Zhou J, Wang JS, Zhang Y, Wang PR, Guo C, Kong LY (2012) Disesquiterpenoid and sesquiterpenes from the flos of Chrysanthemum indicum. Chem Pharm Bull(Tokyo) 60(8):1067–1071
Zhu SY, Yang Y, Yu HD, Ying Y, Zou GL (2005) Chemical composition and antimicrobial activity of the essential oils of Chrysanthemum indicum. J Ethnopharmacol 96(1–2):151–158
Zhu S, Christopher J. Humphries CJ, Michael G. Gilbert MG (2011) Chrysanthemum Linnaeus. In: Wu ZY, Raven PH (eds) Flora of China, vols 20–21 (Asteraceae). Science Press/Missouri Botanical Garden Press, Beijing/St. Louis
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Lim, T.K. (2014). Chrysanthemum indicum. In: Edible Medicinal And Non-Medicinal Plants. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7395-0_18
Download citation
DOI: https://doi.org/10.1007/978-94-007-7395-0_18
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7394-3
Online ISBN: 978-94-007-7395-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)